SKI Market

Indian Indices

Nifty

24,578.35 -346.35
(-1.39%)

Sensex

81,148.22 -1,281.68
( -1.55%)

Bank Nifty

54,940.85 -442.00
( -0.80%)

Nifty IT

37,354.60 -927.95
( -2.42%)

Global Indices

Nasdaq

42,424.12 1,153.74
(2.80%)

Dow Jones

5,865.06 184.15
(3.24%)

Hang Seng

38,283.51 639.25
(1.70%)

Nikkei 225

8,604.98 50.18
(0.59%)

Forex

USD-INR

85.41 0.03
(0.03%)

EUR-INR

96.03 -0.26
(-0.27%)

GBP-INR

113.57 0.08
(0.07%)

JPY-INR

0.59 0.00
(-0.40%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Alivus Life Sciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543322

INE03Q201024

207.0062322

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ALIVUS

30.49

13465.91

EPS(TTM)

Face Value()

Div & Yield %

36.02

2.05

Particulars(INCOME)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)	Mar 2019 ( Cr)
Sales Turnover	2283.21	2161.22	2123.21	1885.17	1537.31	886.42
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	2283.21	2161.22	2123.21	1885.17	1537.31	886.42
Other Income	12.04	28.96	14.70	0.81	11.99	0.44
Stock Adjustments	56.57	84.44	-41.32	70.70	4.64	301.59
Total Income	2351.82	2274.62	2096.59	1956.68	1553.94	1188.45
EXPENDITURE :
Raw Materials	1025.21	1068.56	977.96	948.17	668.66	633.56
Power & Fuel Cost	112.46	115.60	100.92	74.19	76.75	57.81
Employee Cost	258.16	180.18	168.72	149.13	142.28	106.28
Other Manufacturing Expenses	163.64	137.17	124.04	107.32	108.04	77.09
Selling & Administrative Expenses	64.12	65.47	48.64	48.50	42.05	44.20
Miscellaneous Expenses	41.97	36.39	45.56	37.49	32.22	21.35
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	1665.54	1603.36	1465.83	1364.80	1069.99	940.29
Operating Profit	686.29	671.25	630.76	591.89	483.96	248.17
Interest	1.55	0.55	27.96	87.55	33.52	0.61
Gross Profit	684.74	670.70	602.80	504.34	450.44	247.56
Depreciation	53.45	42.09	37.88	33.39	29.37	19.26
Profit Before Tax	631.29	628.61	564.92	470.95	421.07	228.30
Tax	152.21	150.61	137.63	112.75	98.54	25.90
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	8.19	11.04	8.57	6.62	9.43	6.81
Reported Net Profit	470.89	466.96	418.72	351.58	313.10	195.59
Extraordinary Items	-0.53	-0.41	-0.55	-0.44	-0.91	-0.54
Adjusted Net Profit	471.42	467.37	419.27	352.02	314.01	196.13
Adjustment below Net Profit	-5.46	-0.29	-19.50	-0.53	0.47	-108.02
P & L Balance brought forward	1102.06	1021.35	750.79	399.73	86.17	-1.41
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	275.69	385.96	128.65	0.00	0.00	0.00
P & L Balance carried down	1291.80	1102.06	1021.35	750.79	399.73	86.17
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	1125.00	2100.00	1050.00	0.00	0.00	0.00
Dividend Per Share(Rs)	22.50	42.00	21.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	38.43	38.11	34.17	358.76	1597.44	997.92
Earnings Per Share(Adj)-Unit Curr	38.43	38.11	34.17	358.76	1597.44	997.92
Book Value-Unit Curr	190.35	174.51	167.66	768.11	2049.45	449.62
Book Value(Adj)-Unit Curr	190.35	174.51	167.66	768.11	2049.45	449.62

24,578.35 -346.35 (-1.39%)

81,148.22 -1,281.68 ( -1.55%)

54,940.85 -442.00 ( -0.80%)

37,354.60 -927.95 ( -2.42%)

42,424.12 1,153.74 (2.80%)

5,865.06 184.15 (3.24%)

38,283.51 639.25 (1.70%)

8,604.98 50.18 (0.59%)

85.41 0.03 (0.03%)

96.03 -0.26 (-0.27%)

113.57 0.08 (0.07%)

0.59 0.00 (-0.40%)